DaVita
DVA
#1940
Rank
S$12.99 B
Marketcap
S$194.42
Share price
1.32%
Change (1 day)
-2.06%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): S$13.09

According to DaVita's latest financial reports the company's current EPS (TTM) is S$12.95. In 2024 the company made an earnings per share (EPS) of S$14.11 an increase over its 2023 EPS that were of S$9.74.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$13.09-7.22%
2024S$14.1144.94%
2023S$9.7427.26%
2022S$7.65-35.56%
2021S$11.8744.1%
2020S$8.2419.7%
2019S$6.88540.48%
2018S$1.07-76.07%
2017S$4.49-19.31%
2016S$5.57242.52%
2015S$1.62-62.87%
2014S$4.3813.43%
2013S$3.868.45%
2012S$3.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$27.32 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$13.11 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$18.81 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.43-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA